Entero Therapeutics Inc. (ENTO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entero Therapeutics Inc.

    NASDAQ: ENTO · Real-Time Price · USD
    3.15
    0.85 (36.96%)
    At close: Sep 12, 2025, 3:59 PM
    3.14
    -0.32%
    After-hours: Sep 12, 2025, 07:52 PM EDT

    Entero Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.48 -0.27 -0.9 -0.66
    PEG Ratio
    		 0.01 0.00 0.01 0.02
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.15 1.18 4.82 -4.95
    P/FCF Ratio
    		 -0.94 -0.33 -0.59 -0.91
    P/OCF Ratio
    		 -0.94 -0.34 -0.59 -1.2
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.00 0.23 0.32 -0.13
    Quick Ratio
    		 3.03 1.58 0.59 0.77
    Current Ratio
    		 3.03 1.58 1.37 0.77
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a -702.08 -798.42 -5.26K
    Return on Equity
    		 -0.31 -4.38 -5.34 7.48
    Return on Assets
    		 -0.21 -2.29 -2.69 -4.97
    Return on Invested Capital
    		 n/a -3.56 -3.53 -410.96
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist